Groundbreaking TOPSY Trial Validates Long-term Pessary Self-Management for Pelvic Organ Prolapse

What Does the TOPSY Trial Reveal About Pessary Self-Management?

The first long-term randomized controlled trial comparing pessary self-management to clinic-based care has demonstrated both approaches offer equivalent quality of life outcomes at four years. The TOPSY trial, which followed 186 women for four years post-randomization, found no statistically significant difference in pelvic floor-specific quality of life between women who self-managed their pessaries versus those receiving traditional clinic care, while showing self-management to be more cost-effective.

The study, which began with 340 women across 21 UK National Health Service centers, represents a significant advancement in the evidence base for pessary management. Pelvic organ prolapse affects 5-10% of women globally, with pessaries serving as a common first-line treatment. Until now, clinicians have had limited long-term data to guide care delivery models, relying primarily on short-term studies and observational data. The TOPSY trial addresses this gap with robust long-term follow-up data comparing the two main approaches to pessary care. Women in the self-management arm received training to remove, clean and reinsert their pessaries independently, while those in the clinic-based care group attended regular appointments for healthcare professionals to perform these tasks. At four years, researchers found that women in both groups maintained similar pelvic floor-specific quality of life scores as measured by the Pelvic Floor Impact Questionnaire-7 (PFIQ-7), with mean scores of 32.9 in the self-management group versus 31.4 in the clinic-based care group.

Do the Clinical and Economic Outcomes Endorse Self-Management?

A particularly striking finding was the high pessary continuation rate at four years, with 93% of respondents reporting pessary use within the previous six months – significantly higher than previous studies reporting continuation rates of 45-86%. Conversion to surgery was also remarkably low at just 4%, compared to rates of 12-35% in other studies. These findings suggest that both pessary care approaches support long-term management of prolapse symptoms. The self-management group reported a lower proportion of complications (17.9%) compared to the clinic-based group (22.0%), though this difference was not statistically significant at the four-year mark. Only one potentially related serious adverse event was reported in the self-management group over the entire four-year period, reinforcing the safety profile of this approach. Women originally randomized to self-management maintained significantly higher confidence in their ability to insert and remove their pessary and manage pessary-related complications, despite considerable crossover between groups after the initial 18-month study period.

The economic analysis clearly favored self-management, with the intervention proving less costly than clinic-based care while maintaining equivalent quality of life outcomes. The positive incremental net monetary benefit of £2,240 demonstrates that self-management is cost-effective compared to clinic-based care, with a greater than 92% probability of cost-effectiveness at a willingness-to-pay threshold of £20,000 per quality-adjusted life year. The cost difference was primarily driven by reduced healthcare resource utilization in the self-management group during the first 18 months, though this difference narrowed over time. An on-treatment analysis confirmed that resource use remained lower among women who were actively self-managing at four years. These economic findings are particularly relevant in healthcare systems with resource constraints and long waiting lists for women's health services.

Are Methodological Limitations Affecting the Interpretation?

Despite its strengths, the study had limitations, including a 45% loss to follow-up at four years and limited ethnic diversity, with participants predominantly self-reporting as White. This limits the generalizability of findings to diverse populations. The researchers noted that crossover between groups after the 18-month mark may have influenced some results, though the intention-to-treat analysis maintained the integrity of the original randomization. Additionally, the context of the COVID-19 pandemic during the follow-up period may have influenced continuation rates, as women may have opted to continue with pessaries due to limited access to alternative treatments.

The intervention methodology deserves particular attention as it involved a structured approach to teaching self-management. Women randomized to the self-management group received a 30-minute support session with a trained healthcare professional where they practiced insertion and removal techniques, supplemented by an information leaflet and follow-up phone call two weeks later to troubleshoot any problems. This standardized training protocol could serve as a template for healthcare systems looking to implement similar programs. Notably, by the four-year mark, 39% of participants originally assigned to clinic-based care had crossed over to self-management, suggesting growing acceptance of this approach among both patients and providers over time.

What Insights Do Experts Offer?

Lead investigator Dr. Carol Bugge commented, "Our findings demonstrate that with appropriate training and support, self-management is a viable long-term option that maintains women's quality of life while potentially reducing healthcare system burden." This sentiment was echoed in the study's conclusion that clinical services should consider implementing robust self-management protocols for women with the capacity to self-manage.

Could Self-Management Revolutionize Future Women's Health Care?

Looking forward, the researchers conclude that self-management represents a safe, effective, and cost-effective option for women using vaginal pessaries for prolapse. They recommend that clinical services implement robust self-management protocols for women with the capacity to self-manage. Future research should focus on identifying optimal implementation strategies across different clinical contexts and diverse ethnic groups. In resource-constrained healthcare systems with long waiting lists, self-management may help decrease wait times for specialist appointments while potentially preventing symptom progression.

The TOPSY trial provides the strongest evidence to date supporting pessary self-management as a viable long-term option that maintains quality of life, improves patient confidence, reduces complications, and offers significant cost savings. These findings have important implications for clinical practice guidelines and service delivery models in women's health.

In the context of evolving healthcare delivery models, the TOPSY trial aligns with broader industry trends toward patient empowerment and self-care, which have gained additional momentum following the COVID-19 pandemic. As healthcare systems worldwide grapple with resource constraints and backlogs in elective procedures, interventions that effectively shift appropriate care responsibilities to patients while maintaining quality outcomes are increasingly valuable. The economic advantage demonstrated by pessary self-management represents a tangible example of how patient involvement can create efficiencies without compromising care quality – a model that stakeholders across pharmaceutical, medical device, and healthcare delivery sectors are increasingly prioritizing in value-based care initiatives.

Summary

The TOPSY trial, the first long-term randomized controlled study of its kind, followed 186 women across 21 UK NHS centers for four years, comparing pessary self-management to clinic-based care for pelvic organ prolapse. The study found no significant difference in pelvic floor-specific quality of life between the two approaches, with self-management proving more cost-effective. Notable findings include a 93% pessary continuation rate, low 4% surgery conversion rate, and fewer complications in the self-management group. The economic analysis showed a positive incremental net monetary benefit of £2,240 for self-management, with over 92% probability of cost-effectiveness. Despite some limitations, including 45% loss to follow-up and limited ethnic diversity, the study provides strong evidence supporting pessary self-management as a viable, safe, and cost-effective long-term treatment option.